Literature DB >> 9499669

Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases.

R Martino1, A Santamaría, R Pericas, A Sureda, S Brunet.   

Abstract

Infections by Aeromonas spp. are a rare cause of systemic infection in normal and immunocompromised hosts. We report the cases of two patients with acute non-lymphoblastic leukemia who developed septic shock by Aeromonas species with unusual soft-tissue complications. One patient who was undergoing consolidation chemotherapy developed septic shock by Aeromonas hydrophila with rhabdomyolysis and subsequent soft-tissue destruction consistent with myonecrosis. She recovered with combination antibiotic therapy and supportive care. The second patient developed neutropenia due to ganciclovir treatment for post-allogeneic transplant cytomegalovirus antigenemia. He developed a rapidly progressive septic shock due to Aeromonas sobria with rhabdomyolysis, multi-organ failure and bilateral lower limb myonecrosis, and died within 48 hours. The portal of entry was not identified in either case. These cases confirm the potentially aggressive nature of these bacteria in neutropenic cancer patients with an unusual tendency to produce muscular and soft-tissue destruction.

Entities:  

Mesh:

Year:  1997        PMID: 9499669

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  9 in total

1.  Fatal Necrotizing Soft Tissue Infection by Aeromonas hydrophila.

Authors:  Smita Sood; Vidya Nerurkar
Journal:  J Clin Diagn Res       Date:  2014-04-15

2.  Case reports: fatal necrotizing fasciitis caused by Aeromonas sobria in two diabetic patients.

Authors:  Yao-Hung Tsai; Kuo-Chin Huang; Tsung-Jen Huang; Robert Wen-Wei Hsu
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

3.  Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report.

Authors:  L Cudillo; E Ceresoli; L Sarmati; B Mariotti; M Viscione; A De Majo; A Di Veroli; M Andreoni; W Arcese
Journal:  Bone Marrow Transplant       Date:  2014-01-20       Impact factor: 5.483

4.  Soft tissue infections caused by marine bacterial pathogens: epidemiology, diagnosis, and management.

Authors:  Renato Finkelstein; Ilana Oren
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

5.  Aeromonas hydrophila sepsis with septic embolism and rhabdomyolysis in a chronic iron overload haemodialysis patient treated with deferoxamine.

Authors:  Supachat Chompoonuch; Wittaya Wangsomboonsiri; Pawinee Wongprasit; Somnuek Sungkanuparph; Bunyong Phakdeekitcharoen
Journal:  NDT Plus       Date:  2009-03-06

6.  Clinical characteristics and risk factors of Aeromonas bloodstream infections in patients with hematological diseases.

Authors:  Chunhui Xu; Qingsong Lin; Yuanqi Zhao; Guoqing Zhu; Erlie Jiang; Shangzhu Li; Yingchang Mi; Yizhou Zheng; Fengkui Zhang; Xiaofan Zhu; Zhijian Xiao; Mingzhe Han; Jianxiang Wang; Sizhou Feng
Journal:  BMC Infect Dis       Date:  2022-03-29       Impact factor: 3.090

7.  Infection caused by Aeromonas sobria, complicated by lower extremity paraplegia and the cauda equine syndrome in a patient with well-controlled type 2 diabetes.

Authors:  Małgorzata Szafrańska; Jacek Szafrański; Agata Bronisz; Roman Junik
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

Review 8.  Aeromonas sobria necrotizing fasciitis and sepsis in an immunocompromised patient: a case report and review of the literature.

Authors:  Savino Spadaro; Angela Berselli; Elisabetta Marangoni; Anna Romanello; Maria Vittoria Colamussi; Riccardo Ragazzi; Silvia Zardi; Carlo Alberto Volta
Journal:  J Med Case Rep       Date:  2014-09-22

9.  Multidrug-resistant Aeromonas hydrophila causing fatal bilateral necrotizing fasciitis in an immunocompromised patient: a case report.

Authors:  Alejandra Ugarte-Torres; Sarah Perry; Angela Franko; Deirdre L Church
Journal:  J Med Case Rep       Date:  2018-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.